NFLX - Hot Stocks: AMC leads theater stocks; NFLX price target; ADAP gets partnership; MRCY sets new low; FDA hold for BMRN
It might have been a mixed day for the broader averages, but AMC Entertainment (NYSE:AMC) had an unambiguously good session. No, this wasn't a result of meme-stock traders attempting to force another short squeeze -- at least, not completely. Rather, AMC shares reacted to actual positive signs for the movie-theater business. The move also boosted shares of Cinemark (NYSE:CNK), IMAX (NYSE:IMAX) and Cineplex (OTCPK:CPXGF). Looking at some of the day's other big winners, Adaptimmune Therapeutics (NASDAQ:ADAP) scored one of Tuesday's biggest percentage gains. The stock rose on clinical trial data and a collaboration with Roche (OTCQX:RHHBY) that could potentially be worth billions of dollars. Netflix (NASDAQ:NFLX) also recorded a high-profile gain during the session. Shares of the streaming service rose on a positive analyst comment, reaching a new 52-week high. Turning to some of the day's noteworthy decliners, BioMarin Pharmaceutical (NASDAQ:BMRN) dropped after regulators put a hold on one of its
For further details see:
Hot Stocks: AMC leads theater stocks; NFLX price target; ADAP gets partnership; MRCY sets new low; FDA hold for BMRN